Listed

CervoMed Inc.

CRVONasdaqCIK 1053691HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$6.7m, Q2 FY2026
Net income−$6.6m, Q2 FY2026
CervoMed Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k1,526Revenue, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure2,491Revenue, Q4 FY2023, three months to 2023-12-31$2.5m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-17, accession 0001437749-25-007829. Derived: 12-month figure less the 9-month figure.Report this figure2,347Revenue, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure3,289Revenue, Q2 FY2024, three months to 2024-06-30$3.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure1,940Revenue, Q3 FY2024, three months to 2024-09-30$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure2,162Revenue, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure1,917Revenue, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure1,758Revenue, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure323Revenue, Q3 FY2025, three months to 2025-09-30$322.6k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure8.7Revenue, Q4 FY2025, three months to 2025-12-31$8.7k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k1,791Research and development, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure2,855Research and development, Q4 FY2023, three months to 2023-12-31$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0001437749-25-007829. Derived: 12-month figure less the 9-month figure.Report this figure2,814Research and development, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure3,772Research and development, Q2 FY2024, three months to 2024-06-30$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure5,125Research and development, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure7,087Research and development, Q4 FY2024, three months to 2024-12-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure4,838Research and development, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure5,109Research and development, Q2 FY2025, three months to 2025-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure6,040Research and development, Q3 FY2025, three months to 2025-09-30$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure5,830Research and development, Q4 FY2025, three months to 2025-12-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure5,135Research and development, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure4,322Research and development, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Operating income$k(2,675)Operating income, Q3 FY2023, three months to 2023-09-30−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure(2,480)Operating income, Q4 FY2023, three months to 2023-12-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0001437749-25-007829. Derived: 12-month figure less the 9-month figure.Report this figure(2,595)Operating income, Q1 FY2024, three months to 2024-03-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure(2,995)Operating income, Q2 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure(5,396)Operating income, Q3 FY2024, three months to 2024-09-30−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure(7,241)Operating income, Q4 FY2024, three months to 2024-12-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(5,303)Operating income, Q1 FY2025, three months to 2025-03-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,616)Operating income, Q2 FY2025, three months to 2025-06-30−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure(8,044)Operating income, Q3 FY2025, three months to 2025-09-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure(8,332)Operating income, Q4 FY2025, three months to 2025-12-31−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(8,111)Operating income, Q1 FY2026, three months to 2026-03-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,679)Operating income, Q2 FY2026, three months to 2026-06-30−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k2,150Net income, Q3 FY2023, three months to 2023-09-30$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure(2,362)Net income, Q4 FY2023, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0001437749-25-007829. Derived: 12-month figure less the 9-month figure.Report this figure(2,514)Net income, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure(2,317)Net income, Q2 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure(4,754)Net income, Q3 FY2024, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure(6,706)Net income, Q4 FY2024, three months to 2024-12-31−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(4,894)Net income, Q1 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,258)Net income, Q2 FY2025, three months to 2025-06-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure(7,727)Net income, Q3 FY2025, three months to 2025-09-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure(8,087)Net income, Q4 FY2025, three months to 2025-12-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(7,964)Net income, Q1 FY2026, three months to 2026-03-31−$8.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,572)Net income, Q2 FY2026, three months to 2026-06-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Diluted EPS$ per share(0.70)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figurenot reportednot reportednot reported(0.55)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share0.65Basic EPS, Q3 FY2023, three months to 2023-09-30$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figurenot reported(0.41)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure(0.27)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure(0.55)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figurenot reported(0.56)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(0.70)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure(0.84)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figurenot reported(0.86)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(0.64)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure

Balance sheet

Cash and equivalents$22.5m, Q2 FY2026
Shareholders' equity$23.0m, Q2 FY2026
CervoMed Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m10.4Cash and equivalents, Q3 FY2023, at 2023-09-30$10.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001437749-23-031374.Report this figure7.8Cash and equivalents, FY2023, at 2023-12-31$7.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0001437749-25-007829.Report this figure6.4Cash and equivalents, Q1 FY2024, at 2024-03-31$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001437749-24-016615.Report this figure10.0Cash and equivalents, Q2 FY2024, at 2024-06-30$10.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001437749-24-025875.Report this figure7.7Cash and equivalents, Q3 FY2024, at 2024-09-30$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure9.0Cash and equivalents, FY2024, at 2024-12-31$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figure10.5Cash and equivalents, Q1 FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure8.3Cash and equivalents, Q2 FY2025, at 2025-06-30$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure9.4Cash and equivalents, Q3 FY2025, at 2025-09-30$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure8.2Cash and equivalents, FY2025, at 2025-12-31$8.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure7.9Cash and equivalents, Q1 FY2026, at 2026-03-31$7.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure22.5Cash and equivalents, Q2 FY2026, at 2026-06-30$22.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Current assets$m11.8Current assets, Q3 FY2023, at 2023-09-30$11.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031374.Report this figure10.0Current assets, FY2023, at 2023-12-31$10.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001437749-25-007829.Report this figure8.0Current assets, Q1 FY2024, at 2024-03-31$8.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001437749-24-016615.Report this figure47.3Current assets, Q2 FY2024, at 2024-06-30$47.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001437749-24-025875.Report this figure48.8Current assets, Q3 FY2024, at 2024-09-30$48.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure43.1Current assets, FY2024, at 2024-12-31$43.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figure38.6Current assets, Q1 FY2025, at 2025-03-31$38.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure38.1Current assets, Q2 FY2025, at 2025-06-30$38.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure30.6Current assets, Q3 FY2025, at 2025-09-30$30.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure22.9Current assets, FY2025, at 2025-12-31$22.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure15.1Current assets, Q1 FY2026, at 2026-03-31$15.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure26.0Current assets, Q2 FY2026, at 2026-06-30$26.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Total assets$m12.0Total assets, Q3 FY2023, at 2023-09-30$12.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001437749-23-031374.Report this figure10.0Total assets, FY2023, at 2023-12-31$10.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001437749-25-007829.Report this figure8.0Total assets, Q1 FY2024, at 2024-03-31$8.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001437749-24-016615.Report this figure53.2Total assets, Q2 FY2024, at 2024-06-30$53.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001437749-24-025875.Report this figure48.9Total assets, Q3 FY2024, at 2024-09-30$48.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure43.1Total assets, FY2024, at 2024-12-31$43.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figure38.6Total assets, Q1 FY2025, at 2025-03-31$38.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure38.1Total assets, Q2 FY2025, at 2025-06-30$38.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure30.6Total assets, Q3 FY2025, at 2025-09-30$30.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure22.9Total assets, FY2025, at 2025-12-31$22.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure15.1Total assets, Q1 FY2026, at 2026-03-31$15.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure26.0Total assets, Q2 FY2026, at 2026-06-30$26.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Current liabilities$mnot reportednot reportednot reportednot reportednot reported3.9Current liabilities, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figurenot reportednot reportednot reported4.7Current liabilities, FY2025, at 2025-12-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figurenot reportednot reported
Total liabilities$m2.5Total liabilities, Q3 FY2023, at 2023-09-30$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001437749-23-031374.Report this figure2.6Total liabilities, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0001437749-25-007829.Report this figure2.7Total liabilities, Q1 FY2024, at 2024-03-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001437749-24-016615.Report this figure3.2Total liabilities, Q2 FY2024, at 2024-06-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001437749-24-025875.Report this figure3.2Total liabilities, Q3 FY2024, at 2024-09-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure3.9Total liabilities, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figure3.9Total liabilities, Q1 FY2025, at 2025-03-31$3.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure4.6Total liabilities, Q2 FY2025, at 2025-06-30$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure4.6Total liabilities, Q3 FY2025, at 2025-09-30$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure4.7Total liabilities, FY2025, at 2025-12-31$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure4.5Total liabilities, Q1 FY2026, at 2026-03-31$4.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure3.0Total liabilities, Q2 FY2026, at 2026-06-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m9.6Shareholders' equity, Q3 FY2023, at 2023-09-30$9.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure7.4Shareholders' equity, FY2023, at 2023-12-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-13, accession 0001437749-26-008259.Report this figure5.3Shareholders' equity, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure50.0Shareholders' equity, Q2 FY2024, at 2024-06-30$50.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001437749-25-025570.Report this figure45.6Shareholders' equity, Q3 FY2024, at 2024-09-30$45.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure39.2Shareholders' equity, FY2024, at 2024-12-31$39.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure34.6Shareholders' equity, Q1 FY2025, at 2025-03-31$34.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure33.4Shareholders' equity, Q2 FY2025, at 2025-06-30$33.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure26.0Shareholders' equity, Q3 FY2025, at 2025-09-30$26.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001437749-25-033879.Report this figure18.2Shareholders' equity, FY2025, at 2025-12-31$18.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure10.6Shareholders' equity, Q1 FY2026, at 2026-03-31$10.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure23.0Shareholders' equity, Q2 FY2026, at 2026-06-30$23.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure

Cash flow

Operating cash flow−$6.9m, Q2 FY2026
CervoMed Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,468)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001437749-24-034344. Derived: 9-month figure less the 6-month figure.Report this figure(2,538)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0001437749-25-007829. Derived: 12-month figure less the 9-month figure.Report this figure(1,424)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001437749-25-015966.Report this figure(2,202)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001437749-25-025570. Derived: 6-month figure less the 3-month figure.Report this figure(4,855)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001437749-25-033879. Derived: 9-month figure less the 6-month figure.Report this figure(8,051)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(3,894)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,515)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001437749-26-026592. Derived: 6-month figure less the 3-month figure.Report this figure(6,465)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001437749-25-033879. Derived: 9-month figure less the 6-month figure.Report this figure(6,576)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001437749-26-008259. Derived: 12-month figure less the 9-month figure.Report this figure(8,018)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001437749-26-017236.Report this figure(6,918)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001437749-26-026592. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)8.70m, Q3 FY2024
CervoMed Inc., shares, quarterly
Line itemUnitQ4 FY20152015-03-31Q2 FY20152015-06-30Q3 FY20152015-09-30Q2 FY20162016-06-30Q3 FY20162016-09-30Q2 FY20172017-06-30Q3 FY20172017-09-30Q2 FY20182018-06-30Q3 FY20182018-09-30Q3 FY20222022-09-30Q3 FY20232023-09-30Q3 FY20242024-09-30
Diluted shares (weighted)m shares18.6Diluted shares (weighted), Q4 FY2015, three months to 2015-03-3118,614,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-05-11, accession 0001104659-15-036824.Report this figure18.6Diluted shares (weighted), Q2 FY2015, three months to 2015-06-3018,614,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-08-12, accession 0001437749-15-015632.Report this figure18.6Diluted shares (weighted), Q3 FY2015, three months to 2015-09-3018,614,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2015-11-12, accession 0001437749-15-020645.Report this figure10.3Diluted shares (weighted), Q2 FY2016, three months to 2016-06-3010,263,703 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2017-08-14, accession 0001437749-17-014712.Report this figure10.3Diluted shares (weighted), Q3 FY2016, three months to 2016-09-3010,333,898 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2017-11-13, accession 0001437749-17-019012.Report this figure13.9Diluted shares (weighted), Q2 FY2017, three months to 2017-06-3013,872,632 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2018-08-10, accession 0001437749-18-015223.Report this figure14.7Diluted shares (weighted), Q3 FY2017, three months to 2017-09-3014,714,853 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2018-11-13, accession 0001437749-18-020566.Report this figure50.5Diluted shares (weighted), Q2 FY2018, three months to 2018-06-3050,546,021 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2018-08-10, accession 0001437749-18-015223.Report this figure50.6Diluted shares (weighted), Q3 FY2018, three months to 2018-09-3050,572,001 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2018-11-13, accession 0001437749-18-020566.Report this figure0.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30518,140 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001437749-23-031374.Report this figure3.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-303,766,700 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure8.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-308,702,764 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001437749-24-034344.Report this figure

Shares outstanding: 15.12mShares outstanding, period not labelled, at 2026-08-0615,119,096 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001437749-26-026592.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.